Neoglycoprotein preparation of YCP, a polysaccharide from Phoma herbarum YS4108 and immunogenicity evaluation in mice

Journal of China Pharmaceutical University

Volumn 37, Issue 4, 2006, Pages 361-366

  Zhao, Hu ^a   Zhang, Hua ^a   Lu, Ying ^a   Gao, Xiang Dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Immunogenicity; Isotype; Neoglycoprotein; Polysaccharide; YCP

Indexed keywords

BOVINE SERUM ALBUMIN; CARRIER PROTEIN; HAPTEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; NEOGLYCOPROTEIN; POLYSACCHARIDE; POLYSACCHARIDE YCP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNODIFFUSION; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; PHOMA HERBARUM;

EID: 33746812177     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Yang XB, Gao XD, Han F, et al. Purification, characterization and enzymatic degradation of YCP, a polysaccharide from marine filamentous fungus Phoma herbarum YS4108[J]. Biochimie, 2005, 87(8):747-754.
2. Chen Z, Guo QL, Gao XD, et al. The study on the tumor inhibitory effect of YCP (a marine fugal polysaccharide) (I) [J]. Chin J Nat Med, 2005, 3(6): 396-400
3. Yao JF, Wu L, Gao XD, et al. Immuno-enhancing effect of YCP obtained from a marine filamentous fungus Keissleriella sp. YS4108 on mice peritoneal macrophage[J]. J China Pharm Univ, 2004, 35 (6):573-576.
4. Ho MM, Bolgiano B, Corbel MJ. Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines[J]. Vaccine, 2000, 19(7-8):716-725.
5. Fattom A, Fuller S, Propst M, et al. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients[J]. Vaccine, 2004, 23(5):656-663.
6. Carmenate T, Guirola M, Alvarez A, et al. Memory immune response generated in Cereopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine[J]. FEMS Immunol Med Microbiol, 2005, 43(2):133-140.
7. Kanboj KK, Kirchner HL, Kimmel R, et al. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein[J]. J Infect Dis, 2003, 187(10):l 629-1 638.
8. Shafer DE, Toll B, Schuman B, et al. Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetra-fluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides[J]. Vaccine, 2000, 18 (13):1 273-1281.
9. Narita M. Evaluation of ELISA kits for detection of Mycoplasma pneumoniae - specific IgG, IgA, IgM antibodies on the diagnosis of Myroplasma pneumoniae infection in children[J]. Kansenshogaku Zasshi, 2005, 79(7):457-463.
10. Deloron P, Jaureguiberry G, Gaudebout C, et al. Immunological characteristics of malaria antibodies in two regions of Madagascar [J]. J Clin Microbiol, 1987, 25(5):911-915.
11. Gan L, Xin X, Geng M, et al. Immunogenic comparison of two coupling methods of marine polysaccharide to bovine serum albumin [J]. Biol Pharm Bull, 2004, 27(10):l 532-1 536.
12. Saksena R, Ma X, Wade TK, et al. Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa [J]. Carbohydr Res, 2005, 340(14):2 256-2 269.
13. Jin Z, Chu C, Robbins JB, et al. Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice[J]. Infect Immun, 2003, 71(9):5 115-5 120.
14. Libon C, Haeuw JF, Crouzet F, et al. Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodies [J]. Vaccine, 2002, 20(17-18):2 174-2 180.
15. Dearman RJ, Caddick H, Basketter DA, et al. Divergent antibody isotype responses induced in mice by systemic exposure to proteins: a comparison of ovalbumin with bovine serum albumin[J]. Food Chem Toxicol, 2000, 38(4):351-360.
16. Alexander J, Guercio MF, Frame B, et al. Development of experimental carbohydrate-conjugate vaccines composed of Streptocus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope(PADRE)[J]. Vaccine, 2004, 22(19): 2 362-2 367.
17. Muthukkumar S, Stein KE. Immunization with meningococcal polysaccharide-tetanus toxoid conjugate induces polysaccharide-reactive T cells in mice[J]. Vaccine, 2004, 22(9-10):1 290-1 299.
18. McCool TL, Harding CV, Greenspan NS, et al. B-and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier-and polysaccharide-specific immunogenicity [J]. Infect Immumn, 1999, 67(9):4 862-4 869.
19. Mawas F, Feavers IM, Corbel MJ, et al. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Thl/Th2 cytokine profile and IgG subclass response to pneumococal-CRM (197) conjugate vaccines in a murine model [J]. Vaccine, 2001, 19(9-10): l 159-1 166.
20. Crawley A, Raymond C, Wilkie BN. Control of immunoglobulin isotype production by porcine B-cells cultured with cytokines [J]. Vet Immunol Immunopathol, 2003, 91(2):141-154.